Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced that the U.S. Patent and Trademark Office has issued a new patent covering its lead investigational therapy, istaroxime, for intravenous ...

The data indicate it’s worth a shot to try TEER in many with secondary MR, but clinical judgement is critical.

Here’s a quick refresher: the systolic pressure (the top number) is the force of your blood when your heart is actively ...

If istaroxime is approved in the US for acute heart failure, this patent would provide protection to 2039 ...

Although less commonly discussed, low blood pressure can also be linked to heart issues, especially in certain groups of ...